Recently, a Mumbai-based Immunoadoptive Cell Therapy Private Limited (ImmunoACT) announced the approval of India’s first chimeric antigen receptor (CAR) T-cell therapy by the Central Drugs Standard Control Organization (CDSCO) for treating leukaemias (cancers arising from the cells that produce white blood cells) and lymphomas (arising from the lymphatic system).
What is Chimeric Antigen Receptor (CAR) T-cell Therapy?
What are T Cells?
|
Need for such T-cell Therapy:
Role of Central Drugs Standard Control Organization (CDSCO)
|
Verifying, please be patient.
DELHI (Karol Bagh)
GS SCORE, 1B, Second Floor, Pusa Road, Karol Bagh, New Delhi - 110005 (Beside Karol Bagh Metro Station Gate No. 8)
BHUBANESWAR (Jaydev Vihar)
GS SCORE, Plot No.2298, Jaydev Vihar Square, Near HCG Day Care, BBSR - 751013
LUCKNOW (Aliganj)
GS SCORE, 2nd Floor, B-33, Sangam Chauraha, Sector H, Aliganj, Lucknow, UP - 226024